FGF23 blockade induces maladaptive vascular remodelling, reducing pathologically increased arterial stiffness and blood pressure
Clicks: 10
ID: 329618
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
2.7
/100
10 views
9 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #92 of 119 articles by views in nephrology dialysis transplantation
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
ABSTRACT Background and hypothesis Elevated circulating levels of fibroblast growth factor 23 (FGF23) are linked to arterial stiffness and cardiovascular risk, and blocking FGF23 has been proposed as a therapeutic strategy. However, whether FGF23 inhibition is beneficial or detrimental for vascular function remains unknown. Methods We investigated the vascular consequences of blocking FGF23 in spontaneously hypertensive rats (SHR) treated for 14 days with a neutralizing antibody. Arterial stiffness, blood pressure, and extracellular matrix proteins involved in vascular remodelling were evaluated. In addition, Fibrillin-1, Fibronectin, and FGF23 were also analysed in renal arteries from nephrectomized patients. Results FGF23 blockade significantly reduced blood pressure and arterial stiffness in SHR rats and pulse wave velocity values fell below those of WKY controls, indicating abnormally low stiffness and excessive vascular relaxation. This was accompanied by a marked reduction in vasoactive compounds such as endothelin-1, adrenomedullin, and epinephrine, together with a compensatory rise in angiotensin II, III, and IV. Structural and ultrastructural analyses revealed aortic dilation, elastic fibres fragmentation, reduced collagen content, and abnormal vascular smooth muscle cell (VSMC) morphology. At the molecular level, FGF23 blockade decreased Fibrillin-1, Fibulin-5, and Fibronectin expression while increasing Fibulin-4, pointing to a maladaptive extracellular matrix remodelling. In addition, FGF23 neutralization reduced calcium influx in VSMC from SHR and decreased ORAI1 expression suggesting impaired vasomotor control. Human renal arteries from nephrectomized patients with elevated FGF23 also showed increased Fibrillin-1 and Fibronectin expression, correlating with higher pulse pressure. Conclusions FGF23 blockade was associated with excessive arterial softening, hypotension, and structural vascular alterations in SHR rats. These findings support a role for FGF23 in vascular remodelling and blood pressure regulation under the experimental conditions used in this study but should not be directly extrapolated to clinically used anti-FGF23 therapies.
| Reference Key |
openalex_W7214179670
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Raquel María García-Sáez, Ana I Torralbo-Romero, Rodrigo López‐Baltanás, Antonio Rivas-Domínguez, Rafael Serrano-Berzosa, Teresa Obrero, Karen Valdes-Diaz, Daniel Jurado‐Montoya, Enrique Gómez-Gómez, Juan P Campos-Hernandez, Michaela Lellig, Vera Jankowski, Joachim Jankowski, Miguel Fernández-Tenorio, Fernando Leiva-Cepas, María Encarnación Rodríguez-Ortiz, María V. Pendón Ruiz de Mier, Mariano Rodríguez, Cristian Rodelo‐Haad, Juan Rafael Muñoz-Castañeda |
| Journal | nephrology dialysis transplantation |
| Year | 2026 |
| DOI |
10.1093/ndt/gfag215
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.